Pieris Pharmaceuticals (PIRS) PT Raised to $9 at H.C. Wainwright; PRS-080 News 'Not Surprising'
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Pieris Pharmaceuticals (NASDAQ: PIRS) to $9.00 (from $7.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
